MedPath

TARO-LANSOPRAZOLE

TARO-LANSOPRAZOLE

Approved
DIN Number

02402629

Drug Class

Human

Market Date

Mar 22, 2013

Company
HC

sun pharma canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02402629
AIG Number0127666004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A02BC03 LANSOPRAZOLE
Product Specifications
Dosage FormCapsule (Delayed Release)
Route of AdministrationOral
AHFS Classification56:28.36
Health Canada Classification

ACTIVE INGREDIENTS (1)

LANSOPRAZOLEActive
Strength: 30 MG
Monograph: LANSOPRAZOLE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.